Works matching DE "ANTIPHOSPHOLIPID syndrome treatment"
Results: 163
Four-year follow-up of two patients on maintenance therapy with fondaparinux and mycophenolate mofetil for microthrombotic antiphospholipid syndrome.
- Published in:
- Lupus, 2019, v. 28, n. 8, p. 1003, doi. 10.1177/0961203319851863
- By:
- Publication type:
- Article
Safety and efficacy of thrombopoeitin mimetics for refractory immune thrombocytopenia purpura in patients with systemic lupus erythematosus or antiphospholipid syndrome: a case series.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess.
- Published in:
- Lupus, 2018, v. 27, n. 2, p. 177, doi. 10.1177/0961203317738227
- By:
- Publication type:
- Article
Belimumab in primary antiphospholipid syndrome.
- Published in:
- Lupus, 2017, v. 26, n. 10, p. 1123, doi. 10.1177/0961203316682102
- By:
- Publication type:
- Article
Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile.
- Published in:
- Lupus, 2017, v. 26, n. 9, p. 983, doi. 10.1177/0961203317692432
- By:
- Publication type:
- Article
Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study.
- Published in:
- Lupus, 2017, v. 26, n. 3, p. 266, doi. 10.1177/0961203316660203
- By:
- Publication type:
- Article
Stillbirth: the impact of antiphospholipid syndrome?
- Published in:
- 2017
- By:
- Publication type:
- Opinion
Antiphospholipid Syndrome On Cloud (APSOnCloud): web-based monitoring of oral anticoagulation.
- Published in:
- Lupus, 2017, v. 26, n. 2, p. 179, doi. 10.1177/0961203316658558
- By:
- Publication type:
- Article
Systematic review of case reports of antiphospholipid syndrome following infection.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Direct oral anticoagulants in antiphospholipid syndrome: a real life case series.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study).
- Published in:
- Lupus, 2016, v. 25, n. 5, p. 479, doi. 10.1177/0961203315617538
- By:
- Publication type:
- Article
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.
- Published in:
- Lupus, 2016, v. 25, n. 3, p. 301, doi. 10.1177/0961203315611495
- By:
- Publication type:
- Article
New oral anticoagulants in thrombotic antiphospholipid syndrome.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1279, doi. 10.1177/0961203314540968
- By:
- Publication type:
- Article
Catastrophic antiphospholipid syndrome: task force report summary.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1283, doi. 10.1177/0961203314540764
- By:
- Publication type:
- Article
Using the GRADE system in diagnostic strategy: the case of antiphospholipid syndrome.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1292, doi. 10.1177/0961203314543922
- By:
- Publication type:
- Article
untitled.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1225, doi. 10.1177/0961203314549793
- By:
- Publication type:
- Article
The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1327, doi. 10.1177/0961203314548248
- By:
- Publication type:
- Article
Complement C5-inhibitor rEV576 (coversin) ameliorates in-vivo effects of antiphospholipid antibodies.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1324, doi. 10.1177/0961203314546022
- By:
- Publication type:
- Article
International standards for IgG and IgM anti-β2glycoprotein antibody measurement.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1317, doi. 10.1177/0961203314544535
- By:
- Publication type:
- Article
Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1313, doi. 10.1177/0961203314544534
- By:
- Publication type:
- Article
Domain I: the hidden face of antiphospholipid syndrome.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1320, doi. 10.1177/0961203314540354
- By:
- Publication type:
- Article
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1255, doi. 10.1177/0961203314534308
- By:
- Publication type:
- Article
What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)?
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1259, doi. 10.1177/0961203314534307
- By:
- Publication type:
- Article
Identification and treatment of APS renal involvement.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1276, doi. 10.1177/0961203314538687
- By:
- Publication type:
- Article
Antibodies to phosphatidylserine/prothrombin complex and the antiphospholipid syndrome.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1309, doi. 10.1177/0961203314538332
- By:
- Publication type:
- Article
Patient–health care provider relationship: how can it impact on APS (Hughes’ syndrome) adherence to treatment?
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1265, doi. 10.1177/0961203314536480
- By:
- Publication type:
- Article
Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1302, doi. 10.1177/0961203314536479
- By:
- Publication type:
- Article
Long-term persistence of anti-β2 glycoprotein I in treated leprosy patients.
- Published in:
- Lupus, 2014, v. 23, n. 12, p. 1249, doi. 10.1177/0961203314529469
- By:
- Publication type:
- Article
Dealing with refractoriness in obstetric primary antiphospholipid syndrome—often not a matter of success.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Are there additional options for the treatment of refractory obstetric antiphospholipid syndrome?
- Published in:
- 2013
- By:
- Publication type:
- Letter
Primary antiphospholipid syndrome in monozygotic twins.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.
- Published in:
- Lupus, 2013, v. 22, n. 1, p. 6, doi. 10.1177/0961203312465782
- By:
- Publication type:
- Article
‘A new dawn of anticoagulation for patients with antiphospholipid syndrome?’.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Heparin, antiphospholipid antibodies and the brain.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Overview of the 8th meeting of the European Forum on antiphospholipid antibodies.
- Published in:
- 2012
- By:
- Publication type:
- Proceeding
Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome.
- Published in:
- 2011
- By:
- Publication type:
- Letter
13th International Congress on Antiphospholipid Antibodies (APLA 2010).
- Published in:
- Lupus, 2011, v. 20, n. 2, p. 152, doi. 10.1177/0961203310397413
- By:
- Publication type:
- Article
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
- Published in:
- Lupus, 2010, v. 19, n. 4, p. 475, doi. 10.1177/0961203310361489
- By:
- Publication type:
- Article
Primary antiphospholipid syndrome with thrombotic thrombocytopenic purpura: a very unusual association.
- Published in:
- Lupus, 2009, v. 18, n. 9, p. 841, doi. 10.1177/0961203308101958
- By:
- Publication type:
- Article
Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort.
- Published in:
- Lupus, 2009, v. 18, n. 8, p. 752, doi. 10.1177/0961203309103303
- By:
- Publication type:
- Article
Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and Safety.
- Published in:
- ISRN Rheumatology, 2014, p. 1, doi. 10.1155/2014/348726
- By:
- Publication type:
- Article
Mitral valve replacement for Libman-Sacks endocarditis in a patient with antiphospholipid syndrome secondary to systemic lupus erythematosus.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Antiphospholipid antibodies.
- Published in:
- Vascular Medicine, 2017, v. 22, n. 6, p. 545, doi. 10.1177/1358863X17737374
- By:
- Publication type:
- Article
Therapeutic challenges after successful thrombectomy in a patient with an antiphospholipid syndrome associated M1-occlusion: A case report.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Antiphospholipid antibody syndrome and LVAD: What are the chances? A case report and literature review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Oral surgery in patients with antiphospholipid syndrome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
An unlikely cause of shortness of breath.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
A rare cause of recurrent modified Blalock-Taussig shunt thrombosis: Antiphospholipid antibodies.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Recombinant Tissue Plasminogen Activator for the Treatment of Cutaneous Infarctions in Antiphospholipid Antibody Syndrome.
- Published in:
- Angiology, 2001, v. 52, n. 9, doi. 10.1177/000331970105200908
- By:
- Publication type:
- Article
Peripheral B-Cell Subset Distribution in Primary Antiphospholipid Syndrome.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 2, p. 589, doi. 10.3390/ijms19020589
- By:
- Publication type:
- Article